NUVB

Analyst Sentiment

Wall St. Consensus
Buy
9 analysts·Limited coverage
69
Score
7 Buy (78%)2 Hold (22%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
778%
Hold
222%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$10.00
+126.8%
Consensus
$12.00
+172.1%
Bull
$17.00
+285.5%
12-Month Target Range9 analysts
$10.00$12.00$17.00
Current $4.41Consensus
Current Price
$4.41
Upside to Consensus
$7.59

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+52.08%
EPS
FY2028
Rev+24.41%
EPS
FY2029
Rev+42.24%
EPS

Earnings Surprises

Recent Analyst Actions

Jan 27, 2026Truist Financial
Nuvation Bio price target raised to $13 from $11 at Truist
Target:$13.00
+129.9%from $5.66
Jan 21, 2026RBC Capital
Nuvation Bio price target raised to $12 from $9 at RBC Capital
Target:$12.00
+99.7%from $6.01
Jan 12, 2026H.C. Wainwright
Nuvation Bio price target lowered to $17 from $18 at H.C. Wainwright
Target:$17.00
+160.7%from $6.52
Jan 7, 2026UBS
UBS Starts Nuvation Bio Inc (NUVB) at Neutral
Target:$10.00
+17.8%from $8.49
Dec 11, 2025H.C. Wainwright
Nuvation Bio price target raised to $18 from $10 at H.C. Wainwright
Target:$18.00
+128.3%from $7.88
Dec 1, 2025H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on Nuvation Bio Inc (NUVB)
Target:$10.00
+24.4%from $8.04
Nov 24, 2025Truist Financial
Nuvation Bio initiated with a Buy at Truist
Target:$11.00
+57.4%from $6.99
Nov 20, 2025JMP Securities
Nuvation Bio price target raised to $10 from $8 at Citizens JMP
Target:$10.00
+37.2%from $7.29
Nov 4, 2025JMP Securities
Nuvation Bio price target raised to $8 from $6 at Citizens JMP
Target:$8.00
+54.7%from $5.17
Apr 23, 2025JMP Securities
Nuvation Bio initiated with an Outperform at Citizens JMP
Target:$6.00
+188.5%from $2.08
Sep 16, 2024H.C. Wainwright
Nuvation Bio price target lowered to $7 from $8 at H.C. Wainwright
Target:$7.00
+129.5%from $3.05
Apr 17, 2024RBC Capital
Nuvation Bio Inc (NUVB) PT Raised to $5 at RBC Capital
Target:$5.00
+77.9%from $2.81
Mar 28, 2024H.C. Wainwright
Nuvation Bio Inc (NUVB) PT Raised to $8 at H.C. Wainwright on AnHeart deal
Target:$8.00
+101.5%from $3.97
Mar 27, 2024Jefferies
Jefferies Upgrades Nuvation Bio Inc (NUVB) to Buy
Target:$10.00
+247.2%from $2.88
Mar 26, 2024BTIG
BTIG Upgrades Nuvation Bio Inc (NUVB) to Buy, has 'two potentially best-in-class drugs'
Target:$5.00
+122.2%from $2.25
Jan 6, 2023Jefferies
Jefferies Downgrades Nuvation Bio to Hold, Lowers Price Target to $2
Target:$2.00
-1.5%from $2.03
May 4, 2022H.C. Wainwright
HC Wainwright & Co. Initiates Coverage On Nuvation Bio with Buy Rating, Announces Price Target of $14
Target:$14.00
+192.9%from $4.78